Hyosung Chemical Corp.

As of June 30, 2026, Hyosung Chemical Corp. carries a market capitalization of 170.87B, placing it among publicly traded companies globally. Its enterprise value stands at 1.92T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Hyosung Chemical Corp.'s next confirmed earnings release is scheduled for October 30, 2026.

As of June 30, 2026, Hyosung Chemical Corp. has 3.77M shares outstanding.

As of June 30, 2026, Hyosung Chemical Corp. trades at a trailing price-to-earnings ratio of 5.02. The price-to-sales ratio is 0.05, and the price-to-book ratio stands at 0.24.

As of June 30, 2026, Hyosung Chemical Corp. trades at an EV/EBITDA multiple of 7.27 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.83 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.92T versus a market cap of 170.87B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hyosung Chemical Corp. maintains a current ratio of 0.57, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 152.75, indicating elevated leverage, while an interest coverage ratio of 3.12 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Hyosung Chemical Corp. posted a return on equity (ROE) of 4.79, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.97, measuring how efficiently the asset base is converted into earnings. The company generates approximately 2.66B in revenue per employee across its workforce of 980.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.94 indicates how many times Hyosung Chemical Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hyosung Chemical Corp. recorded an income tax benefit of -17.83B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -29.70B and 27.58B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Hyosung Chemical Corp.'s stock has gained approximately 14.40% over the past 52 weeks. The 50-day moving average sits at 57,186.00, while the 200-day moving average is 48,082.50.

Over the twelve months ended June 30, 2026, Hyosung Chemical Corp. generated 2.61T in revenue and converted that into 27.58B in net income, yielding earnings per share of -3,324.76. EBITDA reached 264.56B, while operating income came in at 71.64B.

As of June 30, 2026, Hyosung Chemical Corp. holds 96.07B in cash and equivalents against 1.54T in total debt, resulting in a net debt position of 1.43T. Total book value stands at 703.39B, with working capital of -687.99B providing operational flexibility.

Hyosung Chemical Corp. produced 4.99B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -131.61B in capital expenditures, free cash flow totaled -126.61B - equivalent to -41,511.71 per share.

Over the twelve months ended June 30, 2026, Hyosung Chemical Corp. posted a gross margin of 5.99, reflecting its pricing power and cost economics. The operating margin of 2.75 and net profit margin of 1.06 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -78.18: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -14.29, meaning Hyosung Chemical Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Hyosung Chemical Corp. has an Altman Z-Score of 0.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.